| abstract |
The present invention provides a lyophilized formulation of TAT-NR2B9c as the active agent, particularly the chloride salt. TAT-NR2B9c has shown promise for treating stroke, aneurysm, subarachnoid hemorrhage and other neurological or neurotraumatic diseases. The chloride salt of TAT-NR2B9c shows improved stability compared to the acetate salt form of the previous formulation. The formulation of the chloride salt of TAT-NR2B9c is stable at ambient temperature, thus facilitating the management of the supply of said formulation during transport to a hospital or in an ambulance for administration at the scene of an illness or accident. |